Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
Información
- DOI:
- https://doi.org/10.1002/14651858.CD006771.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 octubre 2009see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Vascular
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Moshe Vardi (MV): formulated the proposal, selected and assessed the quality of trials for inclusion, extracted and entered data for analyses, and wrote the text of the review.
Eran Zittan (EZ): selected and assessed the quality of trials for inclusion, extracted and entered data for analyses.
Haim Bitterman (HB): formulated the proposal, resolved differences in trial selection and assessment of trial quality, and contributed to the text of the review.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
Chief Scientist Office, Scottish Government Health Directorates, The Scottish Government, UK.
Declarations of interest
None known.
Acknowledgements
We would like to thank Dr. Myroslav Lutsyk for his kind remarks and help in translation from Polish.
Version history
Published | Title | Stage | Authors | Version |
2017 Feb 14 | Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism | Review | Lindsay Robertson, James Strachan | |
2009 Oct 07 | Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism | Review | Moshe Vardi, Eran Zittan, Haim Bitterman | |
2009 Jul 08 | Subcutaneous unfractionated heparin for the treatment of venous thromboembolism | Protocol | Moshe Vardi, Haim Bitterman | |
Differences between protocol and review
Some minor adjustments were made in the type of statistical methods used to comply with the available data. Data were available for assessment in two time frames rather than three. Subgroup analysis was performed only if data were available. A meta‐regression model to assess heterogeneity was not performed.